If you got a question, look no further.
We post the most common questions
in our FAQ section.
Please fill in the form below to receive a Free Sample of the Report.
View: There have been a number of positive developments in international cooperation forUzbekistan's pharmaceutical sector in recent months. Having identified the pharmaceutical sector as a keyarea of economic growth, the Uzbek government has been encouraging domestic production ofpharmaceuticals. We note that it has seen some success with this - with an increase of exports reported in2013. However, we project that the pharmaceutical trade balance will remain in negative territory for theforeseeable future, with substantial improvements yet to be made to regulatory and manufacturingstandards, potentially curtailing further growth.Headline Expenditure Projections - Pharmaceuticals: UZS933.7bn (US$504mn) in 2013 to UZS1,218.5bn (US$520mn) in 2014; 30.5% inlocal currency terms and 3.0% in US dollar terms. - Healthcare: UZS7,013.8bn (US$3.35bn) in 2013 to UZS8,584.3bn (US$3.66bn) in 2014; 22.4% in localcurrency terms and 9.1% in US dollar terms.
Industry View 7SWOT 9Industry Forecast 11Pharmaceutical Market Forecast 11Table: Uzbekistan Pharmaceutical Sales, Historical Data and Forecasts 12Healthcare Market Forecast 13Table: Uzbekistan Healthcare Expenditure Trends, Historical Data And Forecasts 15Table: Uzbekistan Government Healthcare Expenditure Trends, Historical Data And Forecasts 15Table: Uzbekistan Private Healthcare Expenditure Trends, Historical Data And Forecasts 16Prescription Drug Market Forecast 16Table: Uzbekistan Prescription Drug Market Indicators, Historical Data And Forecasts 17Patented Drug Market Forecast 18Table: Uzbekistan's Patented Drug Market Indicators, Historical Data And Forecasts 19Generic Drug Market Forecast 19Table: Uzbekistan's Generics Drug Market Indicators, Historical Data And Forecasts 20OTC Medicine Market Forecast 20Table: Uzbekistan Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts 21Pharmaceutical Trade Forecast 22Table: Uzbekistan Pharmaceutical Trade Data And Forecasts (US$mn) 24Other Healthcare Data 25Key Risks To BMI's Forecast Scenario 26Macroeconomic Forecasts 28Economic Analysis 28Table: Uzbekistan - Economic Activity 31Industry Risk Reward Ratings 32Central And Eastern Europe Risk/Reward Ratings 32Uzbekistan Risk/Reward Ratings 38Rewards 38Risks 39Market Overview 41Industry Trends And Developments 43Epidemiology 43Healthcare Sector 45Healthcare Provision 46Health Insurance Sector 48Healthcare Sector Reforms 49Research And Development (R&D) 50Clinical Trials 50International Cooperation 51Regulatory Development 53Counterfeit Drugs 54Intellectual Property Rights 54Pricing And Reimbursement 55Competitive Landscape 57Domestic Pharmaceutical Industry 57Leading Domestic Players 59Table: List Of Companies In Uzpharmsanoat SJSC (as of April 20 2011) 60Pharmaceutical Sector Reforms 61Foreign Pharmaceutical Industry 62Recent Pharmaceutical Industry Developments 63Pharmaceutical Wholesale 65Pharmaceutical Retail 65Company Profile 67Jurabek Laboratories 67Uzpharmsanoat 70Asklepiy Pharmaceutical Company 73Demographic Forecast 75Table: Uzbekistan's Population By Age Group, 1990-2020 ('000) 76Table: Uzbekistan's Population By Age Group, 1990-2020 (% of total) 77Table: Uzbekistan's Key Population Ratios, 1990-2020 78Table: Uzbekistan's Rural And Urban Population, 1990-2020 78Glossary 79Methodology 81Pharmaceutical Expenditure Forecast Model 81Healthcare Expenditure Forecast Model 81Notes On Methodology 82Risk/Reward Ratings Methodology 83Ratings Overview 84Table: Pharmaceutical Risk/Reward Ratings Indicators 84Indicator Weightings 85